title: Cell line differences in bacterially translocated ExoS ADP-ribosyltransferase substrate specificity.
abstract: Exoenzyme S (ExoS) is an ADP-ribosyltransferase (ADPRT) directly translocated into eukaryotic cells by the type III secretory (TTS) process of Pseudomonas aeruginosa. Comparisons of the functional effects of ExoS on human epithelial and murine fibroblastic cells showed that human epithelial cells exhibited an overall increased sensitivity to the effects of bacterially translocated ExoS on cell proliferation, morphology and re-adherence. ExoS was also found to ADP-ribosylate a greater number of low-molecular-mass G (LMMG) proteins in human epithelial cells, as compared to murine fibroblasts. Examination of the cellular mechanism for differences in ExoS ADPRT substrate modification found that the more restricted pattern of substrate modification in murine fibroblasts was not linked to the efficiency of bacterial adherence nor to the efficiency of ExoS internalization by the TTS process. In exploring the cellular nature of patterns of substrate modification, more extensive substrate modification was detected in human and simian cell lines, while rodent cell lines, including rat, mouse and hamster lines, consistently exhibited the more limited pattern of LMMG protein ADP-ribosylation. Patterns of substrate modification were not altered by cellular transformation and occurred independently of cell type. These studies suggest that eukaryotic cell properties, as recognized through studies of cells of different animal origins, affect the substrate targeting of ExoS ADPRT activity, and that this in turn can influence the severity of effects of ExoS on host-cell function.
authors.affiliation: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 165 Ashley Avenue, Suite 309, PO Box 250908, Charleston, SC 29425, USA.
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Rucks
authors.affiliation: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 165 Ashley Avenue, Suite 309, PO Box 250908, Charleston, SC 29425, USA.
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Fraylick
authors.affiliation: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 165 Ashley Avenue, Suite 309, PO Box 250908, Charleston, SC 29425, USA.
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Brandt
authors.affiliation: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 165 Ashley Avenue, Suite 309, PO Box 250908, Charleston, SC 29425, USA.
authors.forename: Timothy S
authors.initials: TS
authors.lastname: Vincent
authors.affiliation: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 165 Ashley Avenue, Suite 309, PO Box 250908, Charleston, SC 29425, USA.
authors.forename: Joan C
authors.initials: JC
authors.lastname: Olson
mesh_terms: D036002:ADP Ribose Transferases / Q000378:metabolism*; D000818:Animals; D001427:Bacterial Toxins / Q000378:metabolism*; D002460:Cell Line; D006224:Cricetinae; D003470:Culture Media; D004847:Epithelial Cells / Q000382:microbiology; D005057:Eukaryotic Cells / Q000201:enzymology* / Q000382:microbiology; D005347:Fibroblasts / Q000382:microbiology; D006801:Humans; D051379:Mice; D011550:Pseudomonas aeruginosa / Q000201:enzymology / Q000472:pathogenicity*; D051381:Rats; D013045:Species Specificity; D013379:Substrate Specificity
chemical_list: D001427:Bacterial Toxins; D003470:Culture Media; D036002:ADP Ribose Transferases; C444820:exoenzyme S